Technion model could replace costly genomic tests with faster pathology analysis. Researchers at Technion - Israel Institute of Technology have developed an artificial intelligence model that could significantly change how doctors in Israel, and potentially worldwide, decide whether breast cancer patients should receive chemothera... [2844 chars]
2026 Copyright © News-Matic.com. All Rights Reserved
